Statistics
Publications
22
Citations
4.9K
H-Index
20
Active since
1999
Kaiko Kunii is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in molecular oncology, medicine, and pharmacology.
Publications per year
1999–2022
22
22
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle, Janeta Popovici-Müller, Nicolaos Palaskas et al. · Science · 2013 · 1.2K citations
Medicine, Cancer Biology, Oncology +17
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Katya Marjon, Michael J. Cameron, Phong Quang et al. · Cell Reports · 2016 · 447 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 22